Investment Highlights: Althea subsidiary Peak Processing Solutions has received its first purchase order from WeedMD RX Inc, a subsidiary of Canadian publicly listed…
Read More
Investment Highlights: Althea has completed its first export shipment of products to UK-based medicinal cannabis distributor Grow Pharma Signed in 2020, the…
Read MoreInvestment Highlights: Althea has completed its first shipment of medicinal cannabis products to Germany Initial shipment of 2,000 units valued at approximately…
Read MoreInvestment Highlights: Althea achieved record sales of $1,190,473 in December 2020, an increase of 40% from November 2020, and the first time monthly sales have…
Read MoreThe growth continues! Althea has officially reached over 5,000 patients. This is an exciting milestone and a great reflection of the relentless hard work from all of the team. Thank you to all our fantastic partners and we look forward to further continued growth in 2020. https://t.co/itYfbPQHZn
Read MoreOur CEO Josh Fegan sat down with @CommSec's Tom Piotrowski to discuss our focus on education & technology to improve patient access to medicinal cannabis & the positive regulatory outlook for new jurisdictions & emerging markets | Video: http://ow.ly/BTEj50v0x8C
Read MoreAlthea is thrilled to announce that we will supply the first UK national medical cannabis pilot targeting 20,000 patients | Read the ASX announcement here: https://www.asx.com.au/asxpdf/20190625/pdf/4462xcgx974f62.pdf $AGH
Read More
©2021 Althea Company Pty Ltd
